Status:
COMPLETED
Investigation of the Effectiveness of Electroacupuncture in Patients Undergoing Coronary Artery Bypass Surgery.
Lead Sponsor:
Kahramanmaras Sutcu Imam University
Conditions:
Protective Effects of Acupuncture in Cardiac Surgery
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
In China, acupuncture has been used for nearly 5,000 years to treat diseases and symptoms. Increasing evidence suggests that acupuncture, acupressure, and electroacupuncture (EA) may be useful in tre...
Detailed Description
The study is a prospective, randomized and controlled study and will be conducted in patients who underwent cardiopulmonary bypass and coronary artery surgery.Randomized patients will be randomly divi...
Eligibility Criteria
Inclusion
- American Society of Anesthesiologists (ASA) classification III,
- 18-65 years old,
- Conscious Open,
- Participating in the study and giving permission to practice acupuncture,
- Does not require emergency or repeat surgery,
- Ejection/Fraction (E/F) ratio of 50-55%
- Patients extubated within 24 hours after transfer to intensive care
Exclusion
- Patients who do not want to participate in the study,
- Patients with systemic diseases such as advanced liver, kidney and lung disease,
- Those with chronic inflammatory diseases (rheumatoid arthritis and psoriasis),
- Patients receiving immune systemic therapy,
- Patients with poor mental status,
- Patients with a history of epilepsy,
- Patients with pacemakers,
- Patients who have had heart surgery and emergency within the last month,
- Patients with atrial fibrillation,
- Patients who have atrial fibrillation and cannot be measured after coming off the pump,
- Patients who were not extubated within 24 hours after transfer to intensive care were excluded from the study.
- Additionally, patients receiving the antidiabetic sulfonylurea or glibenclamide were excluded because these agents have been shown to abolish the cardioprotective effect elicited by ischemic preconditioning.
Key Trial Info
Start Date :
February 8 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 6 2025
Estimated Enrollment :
104 Patients enrolled
Trial Details
Trial ID
NCT06110780
Start Date
February 8 2024
End Date
March 6 2025
Last Update
September 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kahramanmaras Sutcu Imam University Faculty of Medicine
Kahramanmaraş, Turkey (Türkiye), 46040